OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer


Recommended Conferences for Destructivemicrobe substance

Destructivemicrobe substance

A substance derived from a mould or bacterium, or produced synthetically, that destroys (bactericidal) or inhibits the growth (bacteriostatic) of other microorganisms and is thus used to treat infections. Some substances have a narrow spectrum of activity whereas others act against a wide range of both gram-positive and gram-negative organisms, is destructivemicrobe substance.

OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosted 306 open access articles Open Access articlesScientific conference Proceedings, 1 national symposiums and on Key word antibiotics sepsis in Global Events page. Global Events of Conference series make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions of OMICS International Conferences.

Importance and scope:

Numerous pathogens that have become resistant to commonly used antibiotics have been  described in various contexts, including drug-resistant methycillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumoneae, and Mycobacterium tuberculosis. Antibiotics-2015 is the premier event that brings together a unique and International mix of experts, researchers and decision makers from both academia and industry across the globe to exchange their knowledge, experience and research innovations. There is a renewed interest in the antibiotic sector, which is evident from the most recent patents and investments. Bacterial vaccines and new antibiotic classes are gaining a tremendous amount of attention with several product candidates in clinical development. This conference focuses exclusively on antibiotics, bacterial vaccines, and other emerging antibacterial

Market Analysis:

New technologies and the outsourcing of antibiotics to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period. Clinical trial spending in 2010 is an estimated $25 billion and is expected to reach $28.5 billion by 2014. The report provides an overview of clinical development phases, the regulatory issues involved, and the factors influencing clinical trial costs. An overview is provided of new technologies that will be affecting the clinical trial process in the near future.


  • British society of immunology
  • Clinical immunology society
  • Indian immunology society
  • Canadian society for immunology
  • Society for mucosal immunology
  • European society of clinical microbiology and infectious diseases (escmid)
  • European molecular biology organization
  • European mycological association
  • European society for clinical virology
  • Swedish society for microbiology,
  • Swedish society of infectious diseases
  • Swedish society of medical microbiology
  • Swiss society for infectious disease
  • Society for general microbiology
  • Italian association for clinical microbiology
  • International Union of Microbiological Societies
  • American Society for Microbiology
  • Society for General Microbiology
  • World Society for Microbiology
  • Society for Applied Microbiology
  • International Committee on Food Microbiology and Hygiene
  • Canadian Society of Microbiologist
  • International Society for Antiviral Research (ISAR)
  • International Society for Microbial Ecology (ISME)


  • DOW
  • Freeslate
  • Agilent Technologies
  • BASF
  • chemspeed Technologies
  • DRGT
  • LTS
  • Octo plus
  • PHASTquality services
  • PSE 
  • Quotient Clinical
  • ShinEtsu
  • Sotax
  • Freund Pharmatec Ltd.
  • Laboratoria Smeets
  • Quay Pharma
  • novo nordisk
  • Crucell Vaccines Inc.
  • Medimmune
  • Sanofi
  • EMD Serono
  • TEVA Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim
  • Celgene
  • AKRIKHIN arno therapeutics
  • pharmTech

Best Confrences



This page will be updated regularly.

This page was last updated on 09th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
+1-702-508-5200 Ext:8051

Program Enquiries
Media Partners | Advertising